vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $27.6M, roughly 1.6× Maison Solutions Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -227.5%, a 209.5% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs 27.7%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
GRAL vs MSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $27.6M |
| Net Profit | $-99.2M | $-5.0M |
| Gross Margin | — | 23.4% |
| Operating Margin | -285.4% | -4.9% |
| Net Margin | -227.5% | -18.0% |
| Revenue YoY | 14.0% | -10.9% |
| Net Profit YoY | -2.2% | -1840.5% |
| EPS (diluted) | $-2.37 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $27.6M | ||
| Q3 25 | $36.2M | $27.2M | ||
| Q2 25 | $35.5M | $34.4M | ||
| Q1 25 | $31.8M | $32.3M | ||
| Q4 24 | $38.3M | $29.4M | ||
| Q3 24 | $28.7M | $28.2M | ||
| Q2 24 | $32.0M | $16.9M | ||
| Q1 24 | $26.7M | $13.6M |
| Q4 25 | $-99.2M | $-5.0M | ||
| Q3 25 | $-89.0M | $-1.5M | ||
| Q2 25 | $-114.0M | $-287.4K | ||
| Q1 25 | $-106.2M | $1.0M | ||
| Q4 24 | $-97.1M | $-256.0K | ||
| Q3 24 | $-125.7M | $700.9K | ||
| Q2 24 | $-1.6B | $-2.8M | ||
| Q1 24 | $-218.9M | $-549.0K |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 21.8% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 23.4% |
| Q4 25 | -285.4% | -4.9% | ||
| Q3 25 | -346.2% | 0.7% | ||
| Q2 25 | -446.9% | -15.9% | ||
| Q1 25 | -482.5% | 3.7% | ||
| Q4 24 | -358.0% | 3.2% | ||
| Q3 24 | -640.5% | 7.3% | ||
| Q2 24 | -5133.8% | -14.4% | ||
| Q1 24 | -851.1% | -2.3% |
| Q4 25 | -227.5% | -18.0% | ||
| Q3 25 | -245.8% | -5.7% | ||
| Q2 25 | -320.7% | -0.8% | ||
| Q1 25 | -333.6% | 3.1% | ||
| Q4 24 | -253.8% | -0.9% | ||
| Q3 24 | -438.7% | 2.5% | ||
| Q2 24 | -4958.8% | -16.4% | ||
| Q1 24 | -819.3% | -4.0% |
| Q4 25 | $-2.37 | $-0.23 | ||
| Q3 25 | $-2.46 | $-0.08 | ||
| Q2 25 | $-3.18 | $-0.02 | ||
| Q1 25 | $-3.10 | $0.06 | ||
| Q4 24 | $-1.49 | $-0.01 | ||
| Q3 24 | $-3.94 | $0.04 | ||
| Q2 24 | $-51.06 | $-0.16 | ||
| Q1 24 | $-7.05 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $2.6B | $11.6M |
| Total Assets | $2.9B | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | — | ||
| Q3 25 | $126.9M | $1.1M | ||
| Q2 25 | $127.4M | $775.4K | ||
| Q1 25 | $133.9M | $445.4K | ||
| Q4 24 | $214.2M | $355.7K | ||
| Q3 24 | $853.6M | $588.9K | ||
| Q2 24 | $958.8M | $2.1M | ||
| Q1 24 | $199.7M | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | $2.6B | $11.6M | ||
| Q3 25 | $2.2B | $10.1M | ||
| Q2 25 | $2.3B | $11.7M | ||
| Q1 25 | $2.4B | $12.0M | ||
| Q4 24 | $2.5B | $10.9M | ||
| Q3 24 | $2.6B | $11.2M | ||
| Q2 24 | $2.7B | $10.5M | ||
| Q1 24 | — | $13.3M |
| Q4 25 | $2.9B | $75.4M | ||
| Q3 25 | $2.6B | $73.3M | ||
| Q2 25 | $2.7B | $77.4M | ||
| Q1 25 | $2.8B | $82.7M | ||
| Q4 24 | $3.0B | $82.7M | ||
| Q3 24 | $3.1B | $82.1M | ||
| Q2 24 | $3.3B | $82.4M | ||
| Q1 24 | — | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $-1.7M |
| Free Cash FlowOCF − Capex | $-63.9M | — |
| FCF MarginFCF / Revenue | -146.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $-1.7M | ||
| Q3 25 | $-63.2M | $1.1M | ||
| Q2 25 | $-77.0M | $-1.6M | ||
| Q1 25 | $-95.0M | $1.7M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-104.6M | $3.6M | ||
| Q2 24 | $-171.8M | $-2.6M | ||
| Q1 24 | $-207.3M | $-1.4M |
| Q4 25 | $-63.9M | — | ||
| Q3 25 | $-63.6M | — | ||
| Q2 25 | $-77.3M | — | ||
| Q1 25 | $-95.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-105.6M | — | ||
| Q2 24 | $-173.2M | — | ||
| Q1 24 | $-209.8M | — |
| Q4 25 | -146.5% | — | ||
| Q3 25 | -175.8% | — | ||
| Q2 25 | -217.6% | — | ||
| Q1 25 | -298.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -368.4% | — | ||
| Q2 24 | -541.7% | — | ||
| Q1 24 | -785.3% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 9.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
